2025-10-15T18:18:57-05:00 2024-12-31 390859910 BAKER TILLY ADVISORY GROUP LP 1500 RXR PLAZA WEST TOWER UNIONDALE NY 11556 990 2024-01-01 061559393 GLOBAL LYME ALLIANCE INC GLOB 2039691333 1700 EAST PUTNAM AVE SUITE 400 GREENWICH CT 068701366 PAUL ROSS CHAIRMAN 2039691333 2025-10-15 1 1 CATHERINE PETERCSAK P01357092 5167472000 2025-10-15 2024 2025-03-06 01:10:19Z PAUL ROSS 1700 EAST PUTNAM AVE SUITE 400 GREENWICH CT 068701366 2874131 0 X GLOBALLYMEALLIANCE.ORG X 1999 CT GLOBAL LYME ALLIANCE FUNDS RESEARCH, EDUCATION & AWARENESS FOR LYME & TICK-BORNE DISEASES. 23 23 16 400 0 0 3325594 2537495 100000 87630 93841 83120 -298420 -329112 3221015 2379133 960114 991363 0 0 1138978 1054585 0 0 479426 1065887 927110 3164979 2973058 56036 -593925 3957959 3256252 777883 670101 3180076 2586151 X GLOBAL LYME ALLIANCE IS THE LEADING NONPROFIT DEDICATED TO CONQUERING LYME AND OTHER TICK-BORNE DISEASES. OUR MISSION: CURE LYME AND OTHER TICK-BORNE DISEASES THROUGH INNOVATIVE RESEARCH, AWARENESS, AND EMPOWERING THE PATIENT VOICE. 0 0 1208447 0 87630 GLOBAL LYME ALLIANCE (GLA) HAS A STRONG TRACK RECORD OF PROGRAM SERVICE ACCOMPLISHMENTS IN THREE MAJOR AREAS, MEASURED BY EXPENSES: RESEARCH ADVANCEMENTS: GLA INVESTS IN RESEARCH, DRIVING SIGNIFICANT PROGRESS IN LYME AND TICK-BORNE DISEASE STUDIES. THEIR CONTRIBUTIONS INCLUDE GROUNDBREAKING WORK IN DIAGNOSTICS, TREATMENT, AND UNDERSTANDING OF LYME BACTERIA. NOTABLE ACHIEVEMENTS COMPRISE CHARACTERIZING CHRONIC LYME DISEASE, GENOME SEQUENCING OF BORRELIA BURGDORFERI STRAINS, UNCOVERING ANTIBIOTIC RESISTANCE MECHANISMS, AND DOCUMENTING IMMUNE DYSFUNCTION IN PATIENTS. RECENT DISCOVERIES INCLUDE THE ROLE OF CELL WALL-DEFICIENT FORMS (L-FORMS) IN CHRONIC INFECTIONS, POTENTIALLY AIDING EARLY LYME DISEASE CURE.PATIENT SUPPORT: GLA IS COMMITTED TO AIDING PATIENTS, CAREGIVERS, AND LOVED ONES AFFECTED BY THESE DISEASES. THEY OFFER VARIOUS SUPPORT PROGRAMS, SUCH AS ACCESS TO SPECIALISTS, FINANCIAL ASSISTANCE INFORMATION, CLINICAL TRIAL OPPORTUNITIES, EMOTIONAL SUPPORT MENTORSHIP, AND EDUCATIONAL MATERIALS. THEIR HOLISTIC APPROACH ADDRESSES PATIENTS AND FAMILIES' CHALLENGES COMPREHENSIVELY.KNOWLEDGE AND AWARENESS: GLA'S RESEARCH AND EDUCATIONAL INITIATIVES HAVE PLAYED A PIVOTAL ROLE IN ENHANCING UNDERSTANDING AND AWARENESS OF LYME AND TICK-BORNE DISEASES. THEIR FUNDING OF STUDIES CONNECTING LYME DISEASE TO PSYCHIATRIC DISORDERS HAS BROADENED AWARENESS OF THE DISEASES' IMPACT ON PATIENTS' WELL-BEING. MOREOVER, GLA'S DEDICATION TO SHARING EDUCATIONAL RESOURCES AND CLINICAL TRIAL INFORMATION EMPOWERS THE COMMUNITY TO MAKE INFORMED HEALTH DECISIONS. 991363 991363 0 GLOBAL LYME ALLIANCE CONTINUES TO ADVANCE THE RESEARCH AND SCIENCE FOR LYME AND OTHER TICK-BORNE DISEASES THROUGH ITS ROBUST RESEARCH GRANT PROGRAM. GLA'S SCIENTIFIC ADVISORY BOARD (SAB), COMPRISED OF DISTINGUISHED RESEARCHERS IN MULTIDISCIPLINARY FIELDS IN LYME AND TICK-BORNE DISEASE, PROVIDES STRATEGIC GUIDANCE TO GLOBAL LYME ALLIANCE IN ITS REVIEW AND AWARD PROCESS TO ADVANCE RESEARCH AT LEADING INSTITUTIONS WITH A GOAL OF IMPROVING DIAGNOSTICS AND TREATMENT OF LYME AND OTHER TICK-BORNE ILLNESSES.AS THE LEADING PATIENT VOICE LYME NON-PROFIT MEASURED BY OUR AUDIENCE SHARE, GLA GETS INPUT FROM OUR MEDICAL ADVISORY BOARD AND PATIENT ADVOCATES TO DRIVE RESEARCH DISCOVERY; GLA BRIDGES THE GAP BETWEEN PATIENT AND RESEARCH TO INFORM WHERE SCIENCE NEEDS TO GO TO FIND A CURE. 2199810 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 21 0 16 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 23 23 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 AL AR CA FL GA HI IL KS KY MA MD MI MN MS NC NH NJ NM NY OR PA RI SC TN UT VA WI WV X X X JENNIFER KATRITOS COO 2039691333 1700 EAST PUTNAM AVE SUITE 400 GREENWICH CT 068701366 PAUL ROSS CHAIRMAN 20.00 0.00 X X 0 0 0 CHARLES BALDUCCI VICE CHAIR 20.00 0.00 X X 0 0 0 DIANE BLANCHARD VICE CHAIR 20.00 0.00 X X 0 0 0 DEBORAH SICILIANO VICE CHAIR 20.00 0.00 X X 0 0 0 HENRY DOSCH TREASURER 15.00 0.00 X X 0 0 0 JANET VACCARO SECRETARY 4.00 0.00 X X 0 0 0 BRETT KRISTOFF DIRECTOR 2.00 0.00 X 0 0 0 RIDGWAY BARKER DIRECTOR 2.00 0.00 X 0 0 0 EDWARD O'CONNELL DIRECTOR 2.00 0.00 X 0 0 0 LORRIE NADEL DIRECTOR 2.00 0.00 X 0 0 0 NANCY DEL GENIO DIRECTOR 10.00 0.00 X 0 0 0 DAVID GERSTNER DIRECTOR 2.00 0.00 X 0 0 0 ERIN WALKER DIRECTOR 2.00 0.00 X 0 0 0 ROSE ANASTASIO DIRECTOR 2.00 0.00 X 0 0 0 CHRIS CORRINET DIRECTOR 2.00 0.00 X 0 0 0 KAREN KELLY DIRECTOR 2.00 0.00 X 0 0 0 JULIA KNOX-COMEAU DIRECTOR 2.00 0.00 X 0 0 0 LEWIS LEONE DIRECTOR 2.00 0.00 X 0 0 0 STEVEN MARTIN DIRECTOR 2.00 0.00 X 0 0 0 DAVID NOLAN DIRECTOR 2.00 0.00 X 0 0 0 BRENT PATRY DIRECTOR TO 9/3/24 2.00 0.00 X 0 0 0 NORMA RUSSO DIRECTOR 2.00 0.00 X 0 0 0 ALEXANDER TISCH DIRECTOR TO 7/19/24 2.00 0.00 X 0 0 0 MACKENZIE VATH DIRECTOR 2.00 0.00 X 0 0 0 ROBERT KOBRE DIRECTOR 2.00 0.00 X 0 0 0 STEVE LEFKOWITZ DIRECTOR (UNTIL 01/2024) 2.00 0.00 X 0 0 0 KAREN PEETZ DIRECTOR (UNTIL 05/2024) 2.00 0.00 X 0 0 0 AZIZ SYRIANI DIRECTOR (UNTIL 01/2024) 2.00 0.00 X 0 0 0 LAURA MACNEILL CEO (UNTIL 10/2024) 40.00 0.00 X 200969 0 0 TIMOTHY SELLATI CSO (UNTIL 08/2024) 40.00 0.00 X 153948 0 9662 STEVEN PECOCK DIRECTOR OF DEVELOPMENT 40.00 0.00 X 160500 0 0 LINDSY SWIFT DIRECTOR OF MKTG & COMM 40.00 0.00 X 110295 0 0 CARA DEANGELIS DIRECTOR OF RESEARCH 40.00 0.00 X 105544 0 0 731256 0 9662 5 0 1 0 0 893647 1643848 52322 2537495 FEE FOR SERVICE 541700 87630 87630 87630 83120 83120 165886 893647 494998 -329112 -329112 2379133 87630 0 -245992 X 901363 901363 90000 90000 348613 325679 6880 16054 606413 316315 19547 270551 1500 1005 45 450 21251 19725 1059 467 76808 51630 2128 23050 54390 54390 334134 66752 153775 113607 101664 30209 37956 33499 1589 1068 44 477 14343 9712 4631 118350 118350 3194 2147 88 959 6448 4334 179 1935 AWARENESS 216454 203410 446 12598 CLINICAL STUDIES/OTHER 55854 55854 LICENSE FEES & PERMITS 15513 15513 SUPPLIES 3357 2257 93 1007 1820 1679 141 2973058 2199810 293822 479426 1020815 540642 1572935 1484533 761869 709479 25000 64488 26407 228890 228890 3194 0 492791 492791 16867 2400 3957959 3256252 121513 70283 656370 584818 15000 777883 670101 X 1695593 1392483 1484483 1193668 3180076 2586151 3957959 3256252 -593925 0 X 0 1 X 1 0 X 2861182 2734537 2975690 3325594 2537495 14434498 2861182 2734537 2975690 3325594 2537495 14434498 830845 13603653 13537 1206 33630 93841 83120 225334 151430 137454 128568 417452 15077284 342080 0.90230 0.87580 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: FUNDRAISING INCOME - 2022 AMOUNT: $ 151,430. 2023 AMOUNT: $ 137,454. 2024 AMOUNT: $ 128,568. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 228890 228890 0 0 INVESTMENT IN THIRD PARTY 492791 C 492791 X 2485999 106866 106866 2379133 0 2379133 3079924 106866 106866 2973058 0 2973058 PART X, LINE 2: MANAGEMENT HAS EVALUATED GLA'S TAX POSITIONS AND CONCLUDED THAT GLA HAD NOT TAKEN ANY UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF FINANCIAL ACCOUNTING STANDARDS BOARD ("FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") NO. 740. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 90000 0 0 0 0 0 0 90000 0 90000 GERMANY RESEARCH 90000 WIRE TRANSFER 0 BOOK 1 0 0 0 0 0 0 0 PART I, LINE 2: GLA AWARDS GRANTS IN TWO INSTALLMENTS. FIRST GRANT PAYMENT (50%) IS PAID WHEN CONTRACT IS SIGNED. SECOND GRANT PAYMENT IS PAID WHEN A SATISFATORY REPORT IS PROVIDED BY THE ACADEMIC INSTITUION. NYC GALA 794521 728358 66163 191950 105900 133307 GOLF OUTING 227694 165289 62405 54724 5790 1022215 893647 128568 246674 111690 133307 491671 -363103 1 THE CHILDREN'S HOSPITAL CORPORATION BOSTON CHILDREN'S HOSPITAL PO BOX 414413 BOSTON MA 02241 042774441 501(C)(3) 350000 0 RESEARCH TRUSTEES OF TUFTS COLLEGE 169 HOLLAND STREET SOMERVILLE MA 02144 042103634 501(C)(3) 264637 0 RESEARCH JOHNS HOPKINS POTTS 5501 HOPKINS BAYVIEW CIRCLE BALTIMORE MD 21224 520595110 501(C)(3) 100000 0 RESEARCH THE LYME TRIALS DBA THE QUIET EPIDEMIC 43 EDWARD ST 408E NEWBURGH NY 12550 813902710 501(C)(3) 161726 0 ADVOCACY PLAYERS PHILANTHROPY DBA INVISISBLE INTERNATIONAL 1122 KENILWORTH DR SUITE201 TOWNSON MD 21204 276601178 501(C)(3) 25000 0 CONTINUTING MEDICAL EDUCATION 5 0 PART I, LINE 2: GLA AWARDS GRANTS IN TWO INSTALLMENTS. FIRST GRANT PAYMENT (50%) IS PAID WHEN CONTRACT IS SIGNED. SECOND GRANT PAYMENT IS PAID WHEN A SATISFACTORY REPORT IS PROVIDED BY THE ACADEMIC INSTITUTION. X X X X 0 0 0 0 0 0 0 1 0 LAURA MACNEILL CEO (UNTIL 10/2024) 183469 0 17500 0 0 0 0 0 0 0 200969 0 0 0 TIMOTHY SELLATI CSO (UNTIL 08/2024) 145071 0 8877 0 0 0 0 0 9662 0 163610 0 0 0 STEVEN PECOCK DIRECTOR OF DEVELOPMENT 154500 0 6000 0 0 0 0 0 0 0 160500 0 0 0 PART I, LINE 7 THE EXECUTIVE TEAM'S BONUSES ARE BASED ON MEETING GOALS AND OBJECTIVES AS DETERMINE BY THE EXECUTIVE COMMITTEE OF THE BOARD, WITH THE APPROVAL OF THE BOARD OF DIRECTORS AT THE BEGINNING OF EACH YEAR. THE AMOUNT OF THE BONUS IS REVIEWED BY THE EXECUTIVE COMMITTEE AND RECOMMENDED TO THE BOARD. X 4 52322 NYSE 0 0 1 0 PART I, COLUMN (B): THE NUMBER ON PART I, COLUMN B REPRESENTS THE NUMBER OF CONTRIBUTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY BOTH MANAGEMENT AND THE FINANCE COMMITTEE. THE FORM 990 IS THEN DISTRIBUTED TO THE FULL BOARD PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C CONFLICTS OF INTERESTS ARE AFFIRMED ANNUALLY IN WRITING. FURTHERMORE, A DIRECTOR OR OFFICER SHALL DISCLOSE A CONFLICT OF INTEREST (A) PRIOR TO VOTING ON OR OTHERWISE DISCHARGING HIS/HER DUTIES WITH RESPECT TO ANY MATTER INVOLVING THE CONFLICT WHICH COMES BEFORE THE BOARD OR ANY COMMITTEE; (B) PRIOR TO ENTERING INTO ANY CONTRACT OR TRANSACTION INVOLVING THE CONFLICT; AND (C) AS SOON AS POSSIBLE AFTER THE DIRECTOR OR OFFICER LEARNS OF THE CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION'S EXECUTIVE COMMITTEE DETERMINES COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER AND/OR OTHER OFFICERS AND KEY EMPLOYEES BY DOING RESEARCH IN THE MARKETPLACE FOR COMPARABLE POSITIONS. THE BOARD OF DIRECTORS APPROVES COMPENSATION FOR EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC AT GLA.ORG AND UPON REQUEST. PART VI, SECTION A, LINE 1(A) THE BOARD OF DIRECTORS HAS DELEGATED BROAD AUTHORITY TO THE EXECUTIVE COMMITTEE TO RUN THE DAILY OPERATIONS OF THE ORGANIZATION. FORM 990, PART IX, LINE 11G CONSULTING: PROGRAM SERVICE EXPENSES 66,752. MANAGEMENT AND GENERAL EXPENSES 153,775. FUNDRAISING EXPENSES 113,607. TOTAL EXPENSES 334,134.